Tag: harm reduction

  • New Study on Harm Reduction Public Policy

    New Study on Harm Reduction Public Policy

    Image: alexskopje

    R Street Institute has released a new report, “Progressive Except for Nicotine: A Discussion of States’ Inconsistent Adoption of Harm Reduction Public Policy.”

    The study examined the harm reduction policy landscape across tobacco, opioids and cannabis in all 50 U.S. states. Researchers identified several important harm reduction-related policies that have varying levels of acceptance/implementation across different states or are currently in legislative flux: tobacco: state and municipal restrictions on electronic nicotine-delivery systems, also known as e-cigarettes or vapes; opioids: states’ authorization of syringe services programs, decriminalization of drug checking equipment, and presence of state-imposed restrictions on methadone that go beyond federal regulations; and cannabis: the legal status of medical and recreational adult-use cannabis markets in each state.

    Researchers then used this information to rank states as “restrictive,” “moderate” or “permissive” on harm reduction with regard to each substance. These rankings were quantitatively compared for all states, and states deemed “restrictive” on at least one substance were qualitatively examined. 

    The report found that while some states support one type of harm reduction, those same states may actively oppose another type of harm reduction. The report also showed that the five states most restrictive of reduced-risk nicotine products in tobacco harm reduction are California, Massachusetts, New Jersey, New York and Rhode Island, and these states are relatively “permissive” when it comes to opioid harm reduction and cannabis use.

    The researchers have suggested that lawmakers reflect on the inconsistencies between harm reduction policies across substances and put political motivations aside to support harm reduction across all substances.

  • THR Strategies Have Reduced Smoking Rates

    THR Strategies Have Reduced Smoking Rates

    The Asia Harm Reduction Forum 2021 attended by the leading experts in technology, public health policy and science met to discuss the tobacco harm reduction (THR) strategies deployed in various countries, according to a press release from the Canadian Vaping Association.

    “We have known the risks from smoking for many decades. We have known that it is the smoke, not the nicotine, that is responsible. We also know that we can deliver nicotine in ways that have minimal risk,” said David Sweanor, chair of the Center for Health Law, Policy and Ethics and an adjunct professor of law at the University of Ottawa. “As a result, Sweden’s rates of tobacco-related illness and death are by far the lowest that you can see in the European Union. Their smoking rates are now low enough that many people would call it a smoke-free society. When Norway allowed snus products to be more widely available, cigarette smoking fell by half in just 10 years. When Iceland allowed both vaping products and snus into the market, smoking fell by about 40 percent in just three years.”

    For decades, Canada has tried to curb smoking through education and taxation with limited success. Reductions in smoking prevalence had generally slowed, with modest annual declines prior to more mainstream adoption of vaping by smokers. Vaping experienced peak adoption in 2019, which lead to a 7.5 percent decline in cigarette sales.

    “Harm reduction is one of the four pillars of Canada’s drug and substances policy. Policy that makes vaping less appealing to smokers, like flavor restrictions and taxation, is out of step with this policy. In effect, Canada has embraced harm reduction in name but not substance,” said Darryl Tempest, Government Relations Council to the Canadian Vaping Association.

  • WHO Criticized for ‘Backward-Looking’ Approach

    WHO Criticized for ‘Backward-Looking’ Approach

    Tom Miller | Photo: David Parker

    Marking World No Tobacco Day, an international group of independent experts has criticized the World Health Organization (WHO) for its “backward-looking” approach to innovation and new technology, such as vaping products.

    The experts say they are exasperated by the WHO’s “dogmatic hostility” towards new technology and fear the U.N. health agency will squander the opportunity to avoid millions of premature deaths that will be caused by smoking.

    Iowa State attorney general Tom Miller said the WHO has lost its sense of mission and purpose. “It’s as if the WHO has forgotten what it is there to do—to save lives and reduce disease,” Miller said.

    “We can do that by helping and encouraging consumers to switch from cigarettes to lower-risk products. This means being honest about the much lower risks and by using smarter regulation to make switching more attractive.”

    The group of experts criticizing the WHO include David Abrams of the School of Global Public Health, New York University; Tikki Pangestu, visiting professor, Lee Kuan Yew School of Public Policy, National University of Singapore; John Britton, professor of epidemiology at the University of Nottingham; Rajesh Sharan, of North-Eastern Hill University, Shillong, India; David Sweanor, Centre for Health Law, Policy and Ethics, University of Ottawa; and Clive Bates, director of Counterfactual Consulting.

  • ‘Harm Reduction Is Human Right’

    ‘Harm Reduction Is Human Right’

    Photo: Horst Winkler from Pixabay

    The European Tobacco Harm Reduction Advocates (ETHRA) is calling on policymakers to recognize the benefits of tobacco harm reduction in advance of World No Tobacco Day on May 31.

    According to ETHRA, reduced-risk products such as e-cigarettes and snus are providing a gateway out of smoking for millions of Europeans, yet across the continent, consumer access to these products is being denied or is under threat.

    Today, the organization launched a manifesto to promote appropriate regulation of innovative solutions for people who wish to continue using nicotine in far safer forms than smoking tobacco, as well as on behalf of the many smokers who may be able to quit through switching to these products in the future.

    Among other things, the manifesto calls for access to harm reduction, including tobacco harm reduction, to be recognized as a human right; for consumers of safer nicotine products to be recognized as essential stakeholders in discussions of policy; and for the regulation for safer nicotine products to reflect the risks relative to the risks from smoking. 

    What’s more, regulators must recognize that having a wide choice of products and flavors is key to the success of safer nicotine products in enabling people to stop smoking, according to the manifesto. Regulation must consider the harm to adults when considering bans intended to protect youth, and tax policy must consider that high taxation of safer nicotine products increases rates of smoking.

    Comprising 21 consumer associations in 16 European countries, the ETHRA was created to increase understanding about the benefits of “new” risk-reduced nicotine products and to promote recognition of long-term recreational use of nicotine as an incentive for smoking cessation.

  • Nicotine: Not Quite the Villain It’s Made out to Be

    Nicotine: Not Quite the Villain It’s Made out to Be

    The scientific evidence is clear that nicotine itself is not responsible for smoking-related diseases.

    By Ian Jones

    If you are as old as me, and happen to come from the U.K., you may recall Nick O’Teen, one of the central characters in an anti-smoking campaign run by the U.K. Health Education Council (HEC) in the early 1980s. With his cigarette-butt-shaped top hat and bright yellow teeth, O’Teen was the campaign’s arch villain and was regularly apprehended by the campaign’s hero, Superman.

    Now, obviously, Nick O’Teen’s name is a play on the word “nicotine,” so it is reasonable to assume that people who saw the campaign in the 1980s concluded that nicotine in cigarettes is the direct cause of smoking-related illnesses. In fact, according to recent surveys, this is still a commonly held belief, not only in the U.K. but in several other surveyed countries. But, given what we know today, does nicotine deserve this reputation or, as Mitch Zeller, director of the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products, the agency in the USA responsible for overseeing the implementation of tobacco product regulation, has previously asked, is it time for a “rethink within society on nicotine”?

    Let’s start with the basics: What exactly is nicotine, and what does it do?

    Nicotine is a chemical naturally found in tobacco and other related plants, in the same way that caffeine is naturally found in tea. Why does tobacco produce nicotine? Well, the commonly held belief is that nicotine helps protect the tobacco leaves from being eaten by insects and other predators. It does this in two ways.

    First, nicotine has a bitter taste, so it could make the leaves unpalatable to some potential diners. Second, and of more relevance to its namesake Nick O’Teen, nicotine mimics one of the natural chemicals that cells in the nervous system of animals use to communicate with each other. Thus, eating nicotine-containing leaves could impact the normal working of the nervous system (in fact, this could even be fatal to some insects).

    Now, in you and me, the chemical that nicotine mimics, acetylcholine, is found throughout the nervous system and performs a myriad of functions. In the brain specifically, acetylcholine acts a bit like a volume control dial, turning up or turning down signals between brain cells. Which way the dial is turned depends on the brain region and the state of mind at the time.

    This is why nicotine, by mimicking acetylcholine, is said to not only help with attention (volume up) but also relaxation (volume down). It also explains the addictive property of nicotine. In the part of the brain responsible for identifying enjoyable experiences, nicotine can turn the volume up, making the experience of smoking stronger.

    Herein also lies a very important point; the addictive effects of nicotine are usually paired with a particular enjoyable experience. It explains why one of the common tests for tobacco addiction, the Fagerström Test for Nicotine Dependence, was renamed to the Fagerström Test for Cigarette Dependence; addiction to smoking is not solely due to the addictive nature of nicotine alone, but is a result of the interplay between nicotine, acting as volume up, and a series of sensory and other cues (smell, taste, ritual, etc.).

    But hold on a minute; doesn’t nicotine cause cancer and other diseases associated with smoking?

    This is one of the main misunderstandings about nicotine and the answer is simple—no. The scientific evidence is clear that nicotine itself is not responsible for smoking-related diseases. These are caused by other things in smoke, particularly chemicals formed when tobacco is burnt. Remember, tobacco-derived nicotine is an approved medicine and is even available without prescription in many countries.

    This would not be the case if there were serious health risks associated with its use. Furthermore, the use of tobacco products that are not burned during use, such as Scandinavian snus—a tobacco product that is placed under the consumer’s lip—is associated with much lower risks of developing cancer compared to smoking, even though the product also delivers nicotine to the user. The FDA in the U.S. recently acknowledged this by approving modified-risk claims for certain snus products.

    This is not to say, though, that nicotine is risk free. As mentioned above, it is addictive and can reinforce addiction to certain pleasurable behaviors. By mimicking acetylcholine, it can also affect certain biological processes such as the development of new blood vessels. There are also concerns about the potential effects of nicotine exposure in developing brains, an area that certainly deserves more research focus (as well as effective practical measures to prevent minors from accessing nicotine-containing products).

    OK, so the science to date noes not support the notion that nicotine causes cancer, but what about nicotine salts? I hear they are even worse than nicotine.

    I would contend that this is another misunderstanding, this time in part due to a lack of clear explanation by manufacturers as to what nicotine salts are when they first came onto the market. The key point to remember is that nicotine is nicotine, whether in salt form, nonsalt form (“nicotine base”), naturally derived or synthetic. Nicotine salts are simply nicotine attached to something else, in the same way that cooking salt is sodium attached to chloride (i.e. sodium chloride).

    Whether nicotine attaches to something else is simply down to how acidic the environment is. In acidic environments (e.g. an acidic e-liquid), nicotine is in salt form. At the other end of the scale, in alkaline environments, it is in base form (not attached to anything). In the middle (neutral pH), as in our bodies, nicotine is in a mixture of salt and base forms. An interesting aside is that nicotine salts are therefore not a new discovery; historically, e-liquids have been around neutral pH, so they have in fact always contained some nicotine salts.

    In any case, the fact that our bodies like to maintain a “just so” neutral pH means that, from a biological point of view, the form of the nicotine in the liquid does not really matter much as it will conform to a salt/base mix as soon as it comes in contact with the body. What nicotine salts (and acidic e-liquids in general) do is provide a different sensory experience, especially at higher nicotine levels, which some consumers may prefer.

    So, back to Nick O’Teen. Does he deserve his reputation? In my opinion, he was an arch villain of his time. As we’ve gained more understanding over the intervening years about the effects of nicotine in the body, I think we can indeed rethink the role of nicotine in society, just as Mitch Zeller suggests. Nicotine is not risk free and is certainly not something that minors should ever consume given concerns about the impact on the developing brain. 

    Likewise, there are other susceptible groups of people, such as pregnant women, that either should not use nicotine-containing products or, at a minimum, seek medical advice before deciding whether to do so. For most adults, however, nicotine deserves acceptance of its new non-villainous persona as a cause of tobacco-related illness, and to be seen as an adult lifestyle choice, the same as many other adult consumer products.

  • Harm reduction emphasized

    Harm reduction emphasized

    Lars Dahlgren

    Swedish Match’s volume shipments of snus in Scandinavia during the 12 months to the end of December, at 241.3 million cans, were increased by two percent on those of the year to the end of December 2015, 236.3 million cans.

    But despite the volume increase, SM’s share of Sweden’s snus market fell by 1.6 percentage points, from 69.0 percent during 2015 to 67.4 percent during 2016. And it’s share of Norway’s snus market fell by 3.1 percentage points to 53.5 percent.

    Meanwhile, SM’s volume shipments of moist snuff on the US market during 2016, at 131.4 million cans was down by one percent on that of 2015, 132.1 million cans.

    Also in the US, the company’s volume shipments of cigars in 2016, at 1,472 million, was increased by 17 percent on that of 2015, 1,256 million.

    But, during the same period, volume shipments of chewing tobacco, excluding contract manufacturing volumes, at 6,709,000 pounds, was down by nine percent from 7,390,000 lb.

    SM’s worldwide shipments of matches during 2016, at 72.0 billion sticks, were down by two percent on those of 2015, 73.1 billion sticks.

    During the same period, worldwide shipments of lighters fell by one percent from 402.9 million to 399.2 million.

    In announcing its results on Friday, SM said that its sales had increased by six percent to SEK3,957 million during the fourth quarter and by seven percent to SEK15,551 million during the full year. In local currencies, sales had increased by three percent during the fourth quarter and by seven percent during the full year.

    Basic earnings per share amounted to SEK3.61 during the fourth quarter and to SEK27.38 during the full year.

    “I am pleased to report a year of solid growth, with higher sales in all of our product areas and strong operating profit growth,” said CEO Lars Dahlgren.

    “We expanded our efforts in the smokeless arena and continued on the path toward our vision of a world without cigarettes.

    “We delivered very strong cash returns to our shareholders, with both our regular dividend and two payments of special dividends stemming from our sell-downs of shareholdings in Scandinavian Tobacco Group.

    “This past year we have been faced with notable regulatory changes, impacting both 2016 and future periods. We remain committed to being a vocal proponent of the benefits of harm reduction in the tobacco industry and will face these regulatory changes from a position of strength.”